Tapio Vehmas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tapio Vehmas has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Päivi Leino-Arjas
Finnish Institute of Occupational Health, Helsinki, Finland
9 shared publications - Panu Oksa
Clinic of Occupational Medicine, Tampere University Hospital, Tampere, Finland
5 shared publications - Ari Hirvonen
Finnish Institute of Occupational Health
4 shared publications Katariina Luoma
HUS Medical Imaging Center, Helsinki University Central Hospital, Helsinki, Finland
4 shared publications- Päivi Piirilä
Unit of Clinical Physiology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
4 shared publications - Svetlana Solovieva
Finnish Institute of Occupational Health, Työterveyslaitos, Finland
4 shared publications
Latest Publications
- 1 September 2015
- Published by Wolters Kluwer Health in European Journal Of Cancer Prevention
- Vol. 24 (5) , 454
Healthy volunteer effect in a lung cancer screening study
- 1 September 2015
- Published by Wolters Kluwer Health in European Journal Of Cancer Prevention
- Vol. 24 (5) , 454
Healthy volunteer effect in a lung cancer screening study
- 1 October 2014
- Published by Elsevier in European Journal of Radiology
- Vol. 83 (10) , 1983-1987
Chest HRCT signs predict deaths in long-term follow-up among asbestos exposed workers
- 1 October 2014
- Published by Elsevier in European Journal of Radiology
- Vol. 83 (10) , 1983-1987
Chest HRCT signs predict deaths in long-term follow-up among asbestos exposed workers
- Open Access
- 24 September 2014
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 15 (1) , 311
Variations in the TNFα gene and their interactions with the IL4R and IL10 genes in relation to hand osteoarthritis
The development of osteoarthritis (OA) involves inflammation, but the evidence for participation of genes propagating or inhibiting inflammation in the OA process is inconsistent. We investigated the associations of common variants in the TNFα gene, and their interactions with other cytokine genes, with hand OA among Finnish women. This cross-sectional study was based on bilateral hand radiographs of 542 female dentists and teachers which were classified according to the presence of OA (radiographic K-L score ≥ 2 in ≥ 3 joints) using reference images. The genotypes were determined by PCR-based methods. The degree of pairwise linkage disequilibrium (LD) and haplotypes were constructed and analyzed by the SNPStats software. The associations between four TNFα SNPs and hand OA were tested using logistic regression adjusting for age, occupation, and BMI, and fitting a log-additive model of inheritance. Gene-gene interactions of TNFα SNPs with IL4R and IL10 SNPs were examined by stratified logistic regression analyses. Possible interactions of the TNFα SNPs with variants in the previously reported IL1β and IL6 genes in influencing hand OA were also explored. Two TNFα polymorphisms (“-1031” and “-863”) were associated with hand OA (OR = 1.45, 95% CI 1.01-2.07 and 1.55, 1.06-2.25, respectively). These associations retained when adjusting further for IL1β “3954” and IL6 “174”. The TNFα G-A-G haplotype was associated with an increased risk of hand OA (1.61, 1.10-2.37, p = 0.01). Interactions were observed between TNFα “-1031” and IL4R Ser503Pro, TNFα “-1031” and IL10 “-1082”, and TNFα “-863” and IL10 “-1082” SNPs with regard to hand OA (p = 0.012, p = 0.0068, and p = 0.02, respectively). The carriage of the TNFα “-1031” minor allele doubled the risk (2.01, 1.26 - 3.22) only in women with the IL4R Ser/Ser genotype. Similarly, the TNFα “-1031” and “-863” minor alleles were associated with an increased risk of hand OA only in IL10 G/G or A/A homozygotes (2.54, 1.45-4.47 and 2.60, 1.46-4.62, respectively) but not in heterozygotes (G/A). Our results suggest that the TNF α gene variants play a role in the etiology of hand OA. In addition, the findings are suggestive of a gene-gene interaction of the TNF α with IL4R and IL10 genes.
- 24 September 2014
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 15 (1) , 311
Open AccessVariations in the TNFα gene and their interactions with the IL4R and IL10 genes in relation to hand osteoarthritis
The development of osteoarthritis (OA) involves inflammation, but the evidence for participation of genes propagating or inhibiting inflammation in the OA process is inconsistent. We investigated the associations of common variants in the TNFα gene, and their interactions with other cytokine genes, with hand OA among Finnish women. This cross-sectional study was based on bilateral hand radiographs of 542 female dentists and teachers which were classified according to the presence of OA (radiographic K-L score ≥ 2 in ≥ 3 joints) using reference images. The genotypes were determined by PCR-based methods. The degree of pairwise linkage disequilibrium (LD) and haplotypes were constructed and analyzed by the SNPStats software. The associations between four TNFα SNPs and hand OA were tested using logistic regression adjusting for age, occupation, and BMI, and fitting a log-additive model of inheritance. Gene-gene interactions of TNFα SNPs with IL4R and IL10 SNPs were examined by stratified logistic regression analyses. Possible interactions of the TNFα SNPs with variants in the previously reported IL1β and IL6 genes in influencing hand OA were also explored. Two TNFα polymorphisms (“-1031” and “-863”) were associated with hand OA (OR = 1.45, 95% CI 1.01-2.07 and 1.55, 1.06-2.25, respectively). These associations retained when adjusting further for IL1β “3954” and IL6 “174”. The TNFα G-A-G haplotype was associated with an increased risk of hand OA (1.61, 1.10-2.37, p = 0.01). Interactions were observed between TNFα “-1031” and IL4R Ser503Pro, TNFα “-1031” and IL10 “-1082”, and TNFα “-863” and IL10 “-1082” SNPs with regard to hand OA (p = 0.012, p = 0.0068, and p = 0.02, respectively). The carriage of the TNFα “-1031” minor allele doubled the risk (2.01, 1.26 - 3.22) only in women with the IL4R Ser/Ser genotype. Similarly, the TNFα “-1031” and “-863” minor alleles were associated with an increased risk of hand OA only in IL10 G/G or A/A homozygotes (2.54, 1.45-4.47 and 2.60, 1.46-4.62, respectively) but not in heterozygotes (G/A). Our results suggest that the TNF α gene variants play a role in the etiology of hand OA. In addition, the findings are suggestive of a gene-gene interaction of the TNF α with IL4R and IL10 genes.
- Open Access
- 1 July 2013
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 14 (7) , 1081-1087
The Relations of Obesity Indicators and Early Metabolic Disturbance with Upper Extremity Pain
Objectives. To determine whether signs of metabolic disturbance and especially visceral obesity are associated with upper extremity pain.Design. Cohor
- 1 July 2013
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 14 (7) , 1081-1087
Open AccessThe Relations of Obesity Indicators and Early Metabolic Disturbance with Upper Extremity Pain
Objectives. To determine whether signs of metabolic disturbance and especially visceral obesity are associated with upper extremity pain.Design. Cohor
- Open Access
- 4 June 2013
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 13 (1) , 36
Association of genes of protease-antiprotease balance pathway to lung function and emphysema subtypes
The imbalance between proteases and antiproteases has been proposed to participate to the pathogenesis of chronic obstructive pulmonary disease (COPD) and emphysema. Gene level variation in different metalloproteinases, metalloproteinase inhibitors, and cytokines affecting them may contribute to this imbalance and destruction of the lung parenchyma. We investigated whether polymorphisms in selected protease-antiprotease balance pathway genes predispose to different emphysema subtypes (centrilobular, paraseptal, panlobular, and bullae) and airflow limitation among Finnish construction workers. Eleven single nucleotide polymorphisms (SNPs) from seven genes (GC: rs7041 and rs4588; MMP1: rs1799750; MMP9: rs3918242; MMP12: rs652438; TIMP2: rs2277698; TNF: rs1799724 and rs1800629; TGFB1: rs1800469, rs1800470, and rs2241718) were analyzed from 951 clinically and radiologically characterized construction workers. The genotype and haplotype data was compared to different emphysematous signs confirmed with high resolution computed tomography (HRCT), forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and maximal expiratory flow at 50% of FVC (MEF50) by using linear and logistic regression analyses, adjusted for potential confounders. The TIMP2 rs2277698 SNP was associated with overall (p = 0.022) and paraseptal (p = 0.010) emphysema, as well as with FEV1/FVC ratio (p = 0.035) and MEF50 (p = 0.008). The TGFB1 rs2241718 and MMP9 rs3918242 SNPs were associated with centrilobular emphysema (p = 0.022 and p = 0.008), and the TNF rs1800629 SNP with paraseptal emphysema (p = 0.017). In stratified analysis, individuals with at least one TIMP2 rs2277698 or TNF rs1800629 variant allele were found to be at around two-fold risk for pathological paraseptal changes (OR 1.94, 95% CI 1.14-3.30; OR 2.10, 95% CI 1.24-3.56). On the contrary, the risk for pathological centrilobular changes was halved for individuals with at least one MMP9 rs3918242 (OR 0.51, 95% CI 0.30-0.86) or TGFB1 rs2241718 (OR 0.53, 95% CI 0.30-0.90) variant allele, or TGFB1 rs1800469-rs1800470 AT-haplotype (OR 0.55, 95% CI 0.33-0.93). MEF50, in turn, was significantly reduced among individuals with at least one TIMP2 rs2277698 variant allele (p = 0.011). Our findings strengthen the hypothesis of the importance of protease-antiprotease balance in pathogenesis of emphysema and shed light on the aetiology of different emphysema subtypes by associating MMP9 and TGFB1 to centrilobular emphysema, and TIMP2 and TNF to paraseptal emphysema and/or airflow obstruction.
- 4 June 2013
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 13 (1) , 36
Open AccessAssociation of genes of protease-antiprotease balance pathway to lung function and emphysema subtypes
The imbalance between proteases and antiproteases has been proposed to participate to the pathogenesis of chronic obstructive pulmonary disease (COPD) and emphysema. Gene level variation in different metalloproteinases, metalloproteinase inhibitors, and cytokines affecting them may contribute to this imbalance and destruction of the lung parenchyma. We investigated whether polymorphisms in selected protease-antiprotease balance pathway genes predispose to different emphysema subtypes (centrilobular, paraseptal, panlobular, and bullae) and airflow limitation among Finnish construction workers. Eleven single nucleotide polymorphisms (SNPs) from seven genes (GC: rs7041 and rs4588; MMP1: rs1799750; MMP9: rs3918242; MMP12: rs652438; TIMP2: rs2277698; TNF: rs1799724 and rs1800629; TGFB1: rs1800469, rs1800470, and rs2241718) were analyzed from 951 clinically and radiologically characterized construction workers. The genotype and haplotype data was compared to different emphysematous signs confirmed with high resolution computed tomography (HRCT), forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and maximal expiratory flow at 50% of FVC (MEF50) by using linear and logistic regression analyses, adjusted for potential confounders. The TIMP2 rs2277698 SNP was associated with overall (p = 0.022) and paraseptal (p = 0.010) emphysema, as well as with FEV1/FVC ratio (p = 0.035) and MEF50 (p = 0.008). The TGFB1 rs2241718 and MMP9 rs3918242 SNPs were associated with centrilobular emphysema (p = 0.022 and p = 0.008), and the TNF rs1800629 SNP with paraseptal emphysema (p = 0.017). In stratified analysis, individuals with at least one TIMP2 rs2277698 or TNF rs1800629 variant allele were found to be at around two-fold risk for pathological paraseptal changes (OR 1.94, 95% CI 1.14-3.30; OR 2.10, 95% CI 1.24-3.56). On the contrary, the risk for pathological centrilobular changes was halved for individuals with at least one MMP9 rs3918242 (OR 0.51, 95% CI 0.30-0.86) or TGFB1 rs2241718 (OR 0.53, 95% CI 0.30-0.90) variant allele, or TGFB1 rs1800469-rs1800470 AT-haplotype (OR 0.55, 95% CI 0.33-0.93). MEF50, in turn, was significantly reduced among individuals with at least one TIMP2 rs2277698 variant allele (p = 0.011). Our findings strengthen the hypothesis of the importance of protease-antiprotease balance in pathogenesis of emphysema and shed light on the aetiology of different emphysema subtypes by associating MMP9 and TGFB1 to centrilobular emphysema, and TIMP2 and TNF to paraseptal emphysema and/or airflow obstruction.
- 4 August 2012
- Published by Springer Nature in International Archives of Occupational and Environmental Health
- Vol. 86 (6) , 667-672
Lung function predicts mortality: 10-year follow-up after lung cancer screening among asbestos-exposed workers
- 4 August 2012
- Published by Springer Nature in International Archives of Occupational and Environmental Health
- Vol. 86 (6) , 667-672
Lung function predicts mortality: 10-year follow-up after lung cancer screening among asbestos-exposed workers
- 1 July 2012
- Published by SAGE Publications in Acta Radiologica
- Vol. 53 (6) , 643-647
Visually scored calcifications in thoracic arteries predict death: follow-up study after lung cancer CT screening
Background Coronary arterial calcification scoring with special cardiac algorithms predicts death. However, a large number of patients undergo a non-cardiac chest CT for other reasons and the information on such arterial calcifications has so far received little attention. Purpose To explore whether visually detected chest atherosclerotic calcifications, which are unrelated to the indication of chest CT, predict mortality. Material and Methods A total of 504 men (aged 39–81 years, mean 63 years) were previously screened for lung cancer with spiral CT and later visually scored for atherosclerotic calcifications in the aorta and the origin of its great branches, and in coronary arteries. Their mortality was later checked in the national register, at a mean follow-up time of 10.4 years. Cox regression was used, adjusted for age, BMI, smoked pack-years, and asbestos exposure. Results One hundred and sixty deaths occurred during the follow-up, of which 57 were from cardiovascular disease. Calcifications at several sites significantly predicted all-cause and cardiovascular deaths in the enter models. In the backward model, calcifications in the aortic arch (hazard ratio HR = 1.35, 95% confidence interval 1.08–1.69, P = 0.009) and in the brachiocephalic origin (HR = 1.45, 1.15–1.82, P = 0.002) remained independent predictors of all-cause deaths. As regards cardiovascular deaths, calcifications in the left anterior descending artery (HR = 1.86, 1.29–2.67, P = 0.001) and brachiocephalic calcifications (HR = 1.65, 1.09–2.49, P = 0.018) remained independent predictors in the backward models. Conclusion Incidental arterial calcifications in routine chest CT should be actively reported to aid the recognition, preventive measures and medication of early atherosclerosis. The value of interventions after finding such calcifications should be further studied.
- 1 July 2012
- Published by SAGE Publications in Acta Radiologica
- Vol. 53 (6) , 643-647
Visually scored calcifications in thoracic arteries predict death: follow-up study after lung cancer CT screening
Background Coronary arterial calcification scoring with special cardiac algorithms predicts death. However, a large number of patients undergo a non-cardiac chest CT for other reasons and the information on such arterial calcifications has so far received little attention. Purpose To explore whether visually detected chest atherosclerotic calcifications, which are unrelated to the indication of chest CT, predict mortality. Material and Methods A total of 504 men (aged 39–81 years, mean 63 years) were previously screened for lung cancer with spiral CT and later visually scored for atherosclerotic calcifications in the aorta and the origin of its great branches, and in coronary arteries. Their mortality was later checked in the national register, at a mean follow-up time of 10.4 years. Cox regression was used, adjusted for age, BMI, smoked pack-years, and asbestos exposure. Results One hundred and sixty deaths occurred during the follow-up, of which 57 were from cardiovascular disease. Calcifications at several sites significantly predicted all-cause and cardiovascular deaths in the enter models. In the backward model, calcifications in the aortic arch (hazard ratio HR = 1.35, 95% confidence interval 1.08–1.69, P = 0.009) and in the brachiocephalic origin (HR = 1.45, 1.15–1.82, P = 0.002) remained independent predictors of all-cause deaths. As regards cardiovascular deaths, calcifications in the left anterior descending artery (HR = 1.86, 1.29–2.67, P = 0.001) and brachiocephalic calcifications (HR = 1.65, 1.09–2.49, P = 0.018) remained independent predictors in the backward models. Conclusion Incidental arterial calcifications in routine chest CT should be actively reported to aid the recognition, preventive measures and medication of early atherosclerosis. The value of interventions after finding such calcifications should be further studied.
- 3 January 2012
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 140 (11) , 1987-1992
Lung and pleural fibrosis in asbestos-exposed workers: a risk factor for pneumonia mortality
SUMMARY: Lungs exposed to occupational dust may be especially vulnerable to fatal infections. We followed up asbestos-exposed workers (n=590) originally screened for lung cancer with computed tomography and scored for pleuropulmonary fibrosis. We checked these workers' influenza and pneumonia mortality data (ICD-10 codes J10–J18) in the national register. In total, 191 deaths, including 43 deaths from infectious pneumonia, occurred in 6158 person-years of follow-up (mean follow-up time 10·44 years). ‘Some interstitial fibrosis’ [hazard ratio (HR) 2·26, 95% confidence interval (CI) 0·98–5·19, P=0·06] and ‘definite interstitial fibrosis’ (HR 3·70, 95% CI 1·22–11·23, P=0·02) were associated with an increased risk of death from pneumonia compared to no fibrosis. Asbestosis patients, i.e. those with both asbestos exposure and lung fibrosis, therefore appear to be particularly at risk for death from pneumonia. These patients should be vaccinated against influenza and Pneumococcus.
- 3 January 2012
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 140 (11) , 1987-1992
Lung and pleural fibrosis in asbestos-exposed workers: a risk factor for pneumonia mortality
SUMMARY: Lungs exposed to occupational dust may be especially vulnerable to fatal infections. We followed up asbestos-exposed workers (n=590) originally screened for lung cancer with computed tomography and scored for pleuropulmonary fibrosis. We checked these workers' influenza and pneumonia mortality data (ICD-10 codes J10–J18) in the national register. In total, 191 deaths, including 43 deaths from infectious pneumonia, occurred in 6158 person-years of follow-up (mean follow-up time 10·44 years). ‘Some interstitial fibrosis’ [hazard ratio (HR) 2·26, 95% confidence interval (CI) 0·98–5·19, P=0·06] and ‘definite interstitial fibrosis’ (HR 3·70, 95% CI 1·22–11·23, P=0·02) were associated with an increased risk of death from pneumonia compared to no fibrosis. Asbestosis patients, i.e. those with both asbestos exposure and lung fibrosis, therefore appear to be particularly at risk for death from pneumonia. These patients should be vaccinated against influenza and Pneumococcus.
- Open Access
- 7 December 2011
- Published by Springer Nature in BMC Medical Genetics
- Vol. 12 (1) , 157
SERPINE2 haplotype as a risk factor for panlobular type of emphysema
Background: SERPINE2 (serpin peptidase inhibitor, clade E, member 2) has previously been identified as a positional candidate gene for chronic obstructive pulmonary disease (COPD) and has subsequently been associated to COPD and emphysema in several populations. We aimed to further examine the role of SERPINE2 polymorphisms in the development of pulmonary emphysema and different emphysema subtypes. Methods: Four single nucleotide polymorphisms (SNPs) in SERPINE2 were analyzed from 951 clinically and radiologically examined Finnish construction workers. The genotype and haplotype data was compared to different emphysematous signs confirmed with high-resolution computed tomography (HRCT), forced vital capacity (FVC), forced expiratory volume in one second (FEV1), diffusing capacity (DLCO), and specific diffusing capacity (DLCO/VA). Results: Three of the studied SERPINE2 SNPs (rs729631, rs975278, and rs6748795) were found to be in tight linkage disequilibrium. Therefore, only one of these SNPs (rs729631) was included in the subsequent analyses, in addition to the rs840088 SNP which was in moderate linkage with the other three studied SNPs. The rs729631 SNP showed a significant association with panlobular emphysema (p = 0.003). In further analysis, the variant allele of the rs729631 SNP was found to pose over two-fold risk (OR 2.22, 95% CI 1.05-4.72) for overall panlobular changes and over four-fold risk (OR 4.37, 95% CI 1.61-11.86) for pathological panlobular changes. A haplotype consisting of variant alleles of both rs729631 and rs840088 SNPs was found to pose an almost four-fold risk for overall panlobular (OR 3.72, 95% CI 1.56-8.90) and subnormal (OR 3.98, 95% CI 1.55-10.20) emphysema. Conclusions: Our results support the previously found association between SERPINE2 polymorphisms and pulmonary emphysema. As a novel finding, our study suggests that the SERPINE2 gene may in particular be involved in the development of panlobular changes, i.e., the same type of changes that are involved in alpha-1-antitrypsin (AAT) -deficiency.
- 7 December 2011
- Published by Springer Nature in BMC Medical Genetics
- Vol. 12 (1) , 157
Open AccessSERPINE2 haplotype as a risk factor for panlobular type of emphysema
Background: SERPINE2 (serpin peptidase inhibitor, clade E, member 2) has previously been identified as a positional candidate gene for chronic obstructive pulmonary disease (COPD) and has subsequently been associated to COPD and emphysema in several populations. We aimed to further examine the role of SERPINE2 polymorphisms in the development of pulmonary emphysema and different emphysema subtypes. Methods: Four single nucleotide polymorphisms (SNPs) in SERPINE2 were analyzed from 951 clinically and radiologically examined Finnish construction workers. The genotype and haplotype data was compared to different emphysematous signs confirmed with high-resolution computed tomography (HRCT), forced vital capacity (FVC), forced expiratory volume in one second (FEV1), diffusing capacity (DLCO), and specific diffusing capacity (DLCO/VA). Results: Three of the studied SERPINE2 SNPs (rs729631, rs975278, and rs6748795) were found to be in tight linkage disequilibrium. Therefore, only one of these SNPs (rs729631) was included in the subsequent analyses, in addition to the rs840088 SNP which was in moderate linkage with the other three studied SNPs. The rs729631 SNP showed a significant association with panlobular emphysema (p = 0.003). In further analysis, the variant allele of the rs729631 SNP was found to pose over two-fold risk (OR 2.22, 95% CI 1.05-4.72) for overall panlobular changes and over four-fold risk (OR 4.37, 95% CI 1.61-11.86) for pathological panlobular changes. A haplotype consisting of variant alleles of both rs729631 and rs840088 SNPs was found to pose an almost four-fold risk for overall panlobular (OR 3.72, 95% CI 1.56-8.90) and subnormal (OR 3.98, 95% CI 1.55-10.20) emphysema. Conclusions: Our results support the previously found association between SERPINE2 polymorphisms and pulmonary emphysema. As a novel finding, our study suggests that the SERPINE2 gene may in particular be involved in the development of panlobular changes, i.e., the same type of changes that are involved in alpha-1-antitrypsin (AAT) -deficiency.
- 4 June 2011
- Published by Springer Nature in International Archives of Occupational and Environmental Health
- Vol. 85 (2) , 207-213
Lung and pleural CT signs predict deaths: 10-year follow-up after lung cancer screening of asbestos-exposed workers
- 4 June 2011
- Published by Springer Nature in International Archives of Occupational and Environmental Health
- Vol. 85 (2) , 207-213
Lung and pleural CT signs predict deaths: 10-year follow-up after lung cancer screening of asbestos-exposed workers